Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
Status:
Completed
Trial end date:
2023-10-30
Target enrollment:
Participant gender:
Summary
The purpose of the real-world observational prospective study is to access the renoprotective
effects of dulaglutide as well as to explore corresponding mechanisms in patients with Type 2
Diabetic Nephropathy.
Phase:
N/A
Details
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University